AIG
ANAB icon

American International Group’s AnaptysBio ANAB Stock Holding History

American International Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,232
Closed -$208K – 161
2024
Q1 		$208K Sell
9,232
-80
-0.9% -$1.89K ﹤0.01% 2125
2023
Q4 		$199K Sell
9,312
-38
-0.4% -$655 ﹤0.01% 2173
2023
Q3 		$168K Buy
9,350
+198
+2% +$3.78K ﹤0.01% 2222
2023
Q2 		$186K Sell
9,152
-628
-6% -$12.7K ﹤0.01% 2213
2023
Q1 		$213K Buy
9,780
+195
+2% +$4.74K ﹤0.01% 2080
2022
Q4 		$297K Sell
9,585
-35
-0.4% -$988 ﹤0.01% 1896
2022
Q3 		$245K Buy
9,620
+135
+1% +$3.17K ﹤0.01% 2045
2022
Q2 		$193K Sell
9,485
-88
-0.9% -$1.95K ﹤0.01% 2198
2022
Q1 		$237K Sell
9,573
-673
-7% -$20.4K ﹤0.01% 2135
2021
Q4 		$356K Sell
10,246
-307
-3% -$9.74K ﹤0.01% 2024
2021
Q3 		$286K Sell
10,553
-251
-2% -$6.37K ﹤0.01% 2212
2021
Q2 		$280 Sell
10,804
-1,675
-13% -$40.1K ﹤0.01% 2294
2021
Q1 		$269 Buy
12,479
+34
+0.3% +$858 ﹤0.01% 2199
2020
Q4 		$268 Sell
12,445
-358
-3% -$8.69K ﹤0.01% 2114
2020
Q3 		$189K Sell
12,803
-291
-2% -$5.25K ﹤0.01% 2176
2020
Q2 		$293K Sell
13,094
-1,449
-10% -$26.5K ﹤0.01% 1888
2020
Q1 		$205K Sell
14,543
-840
-5% -$12.7K ﹤0.01% 1884
2019
Q4 		$250K Sell
15,383
-129
-0.8% -$3.05K ﹤0.01% 2079
2019
Q3 		$543K Sell
15,512
-109
-0.7% -$5.19K ﹤0.01% 1611
2019
Q2 		$881K Buy
15,621
+2,152
+16% +$155K ﹤0.01% 1382
2019
Q1 		$984K Sell
13,469
-437
-3% -$30.2K ﹤0.01% 1330
2018
Q4 		$887K Buy
13,906
+1,315
+10% +$97.8K ﹤0.01% 1332
2018
Q3 		$1.26M Buy
12,591
+505
+4% +$41.9K ﹤0.01% 1294
2018
Q2 		$859K Buy
12,086
+675
+6% +$56.6K ﹤0.01% 1484
2018
Q1 		$1.19M Sell
11,411
-614
-5% -$69.2K ﹤0.01% 1173
2017
Q4 		$1.21M Buy
12,025
+4,053
+51% +$298K ﹤0.01% 1249
2017
Q3 		$279K Buy
7,972
+4,657
+140% +$126K ﹤0.01% 2092
2017
Q2 		$79K Buy
+3,315
New +$83.3K ﹤0.01% 2857

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

American International Group's ANAB Position: Q2 2024 in Review

American International Group sold out of AnaptysBio (ANAB) in Q2 2024, closing a stake of 9,232 shares — an estimated $208K sold.

American International Group first reported a position in ANAB in Q2 2017 and held it in 28 quarters. The position peaked at $1.26M in Q3 2018. 135 funds tracked by Wall St. Rank hold ANAB as of Q2 2024.

  • American International Group reported no remaining AnaptysBio position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 9,232 AnaptysBio shares in Q2 2024, an estimated $208K.
  • American International Group first reported a position in AnaptysBio in Q2 2017 and held it in 28 quarters.
  • American International Group's AnaptysBio position peaked at $1.26M in Q3 2018.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.